Friday, 19 April 2024 11:46 PM
OR
Login using
Pfizer says COVID-19 pill near 90% protective against hospitalization, death
December 15, 2021 12:56 pm
NEW YORK, Dec 15: Pfizer Inc (PFE.N) on Tuesday said its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.
Pfizer's COVID-19 vaccine trial data shows long-term efficacy in adolescents
November 23, 2021 10:25 am
Nov 23: Pfizer Inc (PFE.N) said on Monday its COVID-19 vaccine provided strong long-term protection against the virus in a late-stage study conducted among adolescents aged 12 to 15 years.
Trending
Just In
- MoHP cautions docs working in govt hospitals not to work in private ones
- Over 400,000 tourists visited Mustang by road last year
- 19 hydropower projects to be showcased at investment summit
- Global oil and gold prices surge as Israel retaliates against Iran
- Sajha Yatayat cancels CEO appointment process for lack of candidates
- Govt padlocks Nepal Scouts’ property illegally occupied by NC lawmaker Deepak Khadka
- FWEAN meets with President Paudel to solicit support for women entrepreneurship
- Koshi provincial assembly passes resolution motion calling for special session by majority votes